Hui-Hua Li Selected Research

5-HT2 Serotonin Receptors

1/2021

Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Hua Li Research Topics

Disease

30	Inflammation (Inflammations) 02/2022 - 01/2011
27	Fibrosis (Cirrhosis) 02/2022 - 09/2012
26	Hypertension (High Blood Pressure) 02/2022 - 04/2002
22	Cardiomegaly (Heart Hypertrophy) 01/2022 - 10/2004
20	Hypertrophy 01/2022 - 10/2004
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2013
10	Heart Diseases (Heart Disease) 02/2022 - 10/2013
9	Heart Failure 01/2022 - 01/2011
8	Atrial Fibrillation 01/2022 - 01/2018
6	Reperfusion Injury 01/2022 - 03/2011
6	Neoplasms (Cancer) 10/2020 - 10/2015
6	Atherosclerosis 01/2020 - 03/2014
6	Myocardial Infarction 01/2020 - 01/2013
5	Abdominal Aortic Aneurysm 05/2019 - 01/2012
5	Ischemia 01/2018 - 03/2011
4	Atrial Remodeling 01/2022 - 01/2019
4	Vascular Remodeling 01/2022 - 11/2016
4	Insulin Resistance 01/2019 - 07/2006
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 10/2015
3	Necrosis 01/2020 - 04/2011
3	Infarction (Infarctions) 03/2016 - 08/2014
3	Cardiotoxicity 01/2016 - 07/2015
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2022 - 02/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 04/2014
2	Cardiac Edema 01/2022 - 01/2021
2	Edema (Dropsy) 01/2022 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 02/2017
2	Cicatrix (Scar) 01/2020 - 04/2016
2	Hypertensive Retinopathy 01/2020 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 06/2019 - 06/2014
2	Vascular System Injuries 01/2018 - 03/2016
2	Carcinogenesis 01/2018 - 09/2006
2	Body Weight (Weight, Body) 01/2017 - 11/2014

Drug/Important Bio-Agent (IBA)

31	Angiotensin IIIBA 02/2022 - 10/2011
18	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2004
11	CytokinesIBA 02/2022 - 11/2011
9	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2022 - 03/2011
7	Superoxides (Superoxide)IBA 02/2022 - 11/2011
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2011
7	UbiquitinIBA 01/2022 - 10/2004
7	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019 - 11/2011
7	CollagenIBA 01/2017 - 10/2011
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2011
5	Apolipoproteins E (ApoE)IBA 12/2021 - 10/2015
5	NF-kappa B (NF-kB)IBA 01/2020 - 11/2011
5	Pharmaceutical PreparationsIBA 01/2020 - 06/2013
5	Ligases (Synthetase)IBA 01/2016 - 10/2004
4	AngiotensinsIBA 01/2022 - 03/2014
4	Messenger RNA (mRNA)IBA 12/2021 - 09/2006
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2006
4	CalcineurinIBA 01/2021 - 10/2004
4	Chemokine ReceptorsIBA 10/2020 - 11/2016
4	Desoxycorticosterone Acetate (DOCA)FDA Link 12/2019 - 11/2016
4	SaltsIBA 12/2019 - 11/2016
4	Interleukin-6 (Interleukin 6)IBA 12/2018 - 09/2012
4	salicylhydroxamic acid (SHAM)IBA 01/2017 - 11/2011
3	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2011
3	LipidsIBA 10/2021 - 01/2014
3	Connexin 43 (Connexin43)IBA 01/2021 - 01/2018
3	LDN 57444IBA 10/2020 - 01/2020
3	SB 225002IBA 10/2020 - 12/2019
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2020 - 09/2012
3	Neutralizing AntibodiesIBA 01/2020 - 03/2014
3	Gallic AcidIBA 01/2020 - 01/2019
3	VO-OHpicIBA 01/2020 - 01/2019
3	Desoxycorticosterone (Deoxycorticosterone)IBA 12/2019 - 11/2016
3	Acetates (Acetic Acid Esters)FDA Link 12/2019 - 11/2016
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 11/2014
3	Neurotransmitter Agents (Neurotransmitter)IBA 11/2014 - 11/2011
3	Small Interfering RNA (siRNA)IBA 01/2013 - 10/2004
3	Transcription Factors (Transcription Factor)IBA 11/2011 - 07/2006
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2022 - 11/2007
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2022 - 01/2021
2	FluorineIBA 12/2021 - 08/2017
2	FluoridesIBA 12/2021 - 08/2017
2	Vascular Endothelial Growth Factor CIBA 01/2021 - 01/2020
2	Deubiquitinating EnzymesIBA 10/2020 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2018
2	4(4- (5- nitro- furan- 2- ylmethylene)- 3,5- dioxo- pyrazolidin- 1- yl)- benzoic acid ethyl esterIBA 01/2020 - 10/2018
2	Chymotrypsin FDA Link 01/2020 - 01/2020
2	CholesterolIBA 01/2020 - 01/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 11/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2019
2	c-Mer Tyrosine KinaseIBA 01/2020 - 01/2020
2	oxidized low density lipoproteinIBA 01/2020 - 01/2018
2	TensinsIBA 01/2020 - 01/2018
2	ApolipoproteinsIBA 01/2020 - 01/2020
2	CXC ChemokinesIBA 12/2019 - 05/2019
2	ResveratrolIBA 12/2019 - 01/2019
2	AdiponectinIBA 01/2019 - 06/2014
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2019 - 12/2018
2	C-Reactive ProteinIBA 01/2019 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 12/2018 - 03/2011
2	InterleukinsIBA 12/2018 - 01/2018
2	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 01/2018 - 01/2018
2	ChemokinesIBA 01/2018 - 03/2014
2	Matrix Metalloproteinases (MMPs)IBA 04/2016 - 01/2013

Therapy/Procedure

5	Therapeutics 01/2020 - 08/2009
2	Ligation 01/2022 - 11/2011